Antibodies

Antibodies

Primary Antibodies

P53

TNFRSF1A

Human

WB

IF

FC

IHC

Rabbit

Unconjugated

IgG

Ig

Polyclonal

Druggable Genome

ES Cell Differentiation/IPS

Protein Kinase

Transcription Factors

Transmembrane

Phosphatase

Secreted Protein

Stem cell - Pluripotency

Protease

Pathways in cancer

MAPK signaling pathway

Cell cycle

Chronic myeloid leukemia

Wnt signaling pathway

TGF-beta signaling pathway

Colorectal cancer

Prostate cancer

Small cell lung cancer

Thyroid cancer

Bladder cancer

Endometrial cancer

Huntington's disease

Metabolic pathways

Maturity onset diabetes of the young

Melanoma

Renal cell carcinoma

Ubiquitin mediated proteolysis

Acute myeloid leukemia

Pancreatic cancer

Purine metabolism

Pyrimidine metabolism

RNA polymerase

Adipocytokine signaling pathway

Amyotrophic lateral sclerosis (ALS)

Apoptosis

Basal cell carcinoma

ErbB signaling pathway

Glioma

Jak-STAT signaling pathway

Neurotrophin signaling pathway

Non-small cell lung cancer

Notch signaling pathway

RNA degradation

Adherens junction

Alzheimer's disease

Cytokine-cytokine receptor interaction

DNA replication

Melanogenesis

Nucleotide excision repair

Oocyte meiosis

PPAR signaling pathway

p53 signaling pathway

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

Dorso-ventral axis formation

Focal adhesion

Insulin signaling pathway

Regulation of actin cytoskeleton

Ribosome

Tight junction

Antigen processing and presentation

Basal transcription factors

Chemokine signaling pathway

Circadian rhythm - mammal

Cysteine and methionine metabolism

Dilated cardiomyopathy

Endocytosis

Fc gamma R-mediated phagocytosis

GnRH signaling pathway

Hypertrophic cardiomyopathy (HCM)

Leukocyte transendothelial migration

Long-term depression

Long-term potentiation

Lysine degradation

Pathogenic Escherichia coli infection

Primary immunodeficiency

Progesterone-mediated oocyte maturation

Spliceosome

Valine

leucine and isoleucine degradation

mTOR signaling pathway

2